The rate of promoter methylation in MDM2 gene was greater in brain cancer compared to the standard tissues based on sample type, different cancers stages, ethnic background, sex, weight, age, histopathologic subtypes, and TP53 mutation status. This evidence concerns the gene MDM2 and brain cancer.